Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.068 | 0.7 |
mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.068 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |